Abstract
Serum thyroid-stimulating hormone (TSH), free thyroxine (FT4) and total tri-iodothyronine (TT3) concentrations were measured in 45 postmenopausal breast cancer patients before adjuvant treatment with tamoxifen and at 3- and 6-month intervals. A significant increase in TSH (p = 0.002) at the end of 3 months and a subsequent decrease at the end of 6 months was noted. There were no significant changes in TT3 and FT4. We concluded that tamoxifen therapy in postmenopausal women may result in a reversible increase in TSH after 3 months.
| Original language | English |
|---|---|
| Pages (from-to) | 43-45 |
| Number of pages | 3 |
| Journal | Oncology |
| Volume | 56 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1999 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adjuvant therapy
- Breast cancer
- Tamoxifen
- Thyroid function
Fingerprint
Dive into the research topics of 'Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver